48 Biggest Movers From Yesterday
Gainers
Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
61 Biggest Movers From Yesterday
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
Expert Ratings For Theravance Biopharma
Within the last quarter, Theravance Biopharma (NASDAQ:TBPH) has observed the following analyst ratings:
JP Morgan Upgrades Theravance Biopharma to Neutral, Raises Price Target to $12
JP Morgan analyst Anupam Rama upgrades Theravance Biopharma (NASDAQ:TBPH) from Underweight to Neutral and raises the price target from $7 to $12.
Theravance Biopharma Q3 Adj. EPS $(0.46) Beats $(0.55) Estimate, Sales $13.19M Miss $14.69M Estimate
Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.55) by 16.36 percent. This is a 60.34 percent increase over losses of $(1.16) per share
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.